Reagents News and Research

RSS

UB program secures $12.8 million to improve the quality of global HIV research

The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program for NIH-funded laboratories and research networks across the globe conducting HIV and infectious disease research.

16 Jun 2022

Implementing practical surface SARS-CoV-2 surveillance in public health labs and schools

Surface sampling for SARS-CoV-2 RNA has shown promise to detect the exposure of environments to infected individuals shedding the virus who would not otherwise be detected.

15 Jun 2022

MolGen Showcases Automated High Throughput Laboratory Solutions at the Analytica Fair in Munich

MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA/RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the Analytica Fair, in Munich, on the 21st- 24th of June 2022.

From MolGen 14 Jun 2022

Implementing remote laboratory activity to teach students about enzyme kinetics

The COVID-19 pandemic forced teachers across the globe to embrace remote learning. Although adapting existing materials was relatively easy for lecture-based courses that revolved around theory, teaching laboratory classes remotely presented a formidable challenge.

14 Jun 2022

LabVantage Solutions Adds Mixed Reality Technology to Its Advanced LIMS Platform

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, announced it has signed a global cooperation agreement with Holo4Labs (H4L).

From LabVantage Solutions 9 Jun 2022

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery

Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.

From Axol Bioscience Ltd 8 Jun 2022

INTEGRA’s VOYAGER pipette simplifies testing of air purifiers

Scientists at Aerosol Research and Engineering Labs (ARE Labs) are using the VOYAGER adjustable tip spacing pipette from INTEGRA Biosciences to increase the throughput of their bioaerosol detection protocols. This innovative pipette is speeding up serial dilutions and microbial plating, allowing the team to efficiently test the ability of purifiers to reduce the presence of microbes in circulating air.

From INTEGRA Biosciences 6 Jun 2022

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector.

From MIP Discovery 19 May 2022

Saving lives with living cells: Beckman Coulter Life Sciences launches AQUIOS STEM System to provide a new solution for stem cell analysis

Creating the industry’s first stem cell analysis update in nearly 25 years, Beckman Coulter Life Sciences – a global leader in laboratory automation and innovation – launches an evolution of the gold standard in hematopoietic stem cell enumeration, the AQUIOS STEM System.

13 May 2022

Researchers use electricity to design tool that may help create pharmaceutical compounds

What do gunpowder, penicillin and Teflon all have in common? They were inventions that took the world by storm, but they were all created by complete accident.

4 May 2022

Exploring Populations of B and T Cells in Lymph Nodes of Patients Diagnosed with COVID-19 via Microscopy and Image Analysis

My work is focused on looking at the dynamics of B/T cell populations within lymph nodes from patients that had recovered from COVID-19. My role in this research was developing and implementing microscopy image analysis techniques using methods and instrumentation in part supplied by TissueGnostics.

From TissueGnostics 26 Apr 2022

New LabVantage Forensic Navigator™ Seamlessly Manages Vast Data Flows Over the Entire Forensic Life Cycle

Purpose-Built End-to-End Forensic Informatics Platform Goes Beyond LIMS to Organize and Integrate Forensic Data from Diverse Sources, Providing Unparalleled Functionality and Ease of Use.

From LabVantage Solutions 25 Apr 2022

Sri Lanka’s healthcare system heavily affected by the current economic crisis

Sri Lanka's acute economic crisis has begun to tell on its health care system with critical medicines running out for want of hard currency to import supplies, experts say.

22 Apr 2022

Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins

A new study aimed to generate, characterize, and optimize Abs against SARS-CoV-2 proteins.

12 Apr 2022

What does the Future of Microfluidics within Research Look Like?

We speak to France Hamber, CEO of Fluigent, about their microfluidics solutions and how they are allowing scientists to focus more on the science than the setup.

From Fluigent 11 Apr 2022

SARS-CoV-2 detected using smartphone biosensor

Researchers describe the use of RT-LAMP in combination with particle diffusometry to detect SARS-CoV2 in saliva samples.

7 Apr 2022

Researchers design RNA molecules for delivering therapies directly to beta cells

Investigators at the University of Miami Miller School of Medicine have designed RNA molecules that home to human pancreatic beta cells, the cells that produce insulin and are destroyed in patients with type 1 and type 2 diabetes.

7 Apr 2022

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

From Sino Biological Inc. 6 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

Arrayjet introduces Mercury range of next-generation microarray printers

Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing.

From Arrayjet Ltd 4 Apr 2022